DCE-MRI Tumor Vascular Parameters in Two Preclinical Patient-Derived Orthotopic Xenograft Models of Glioblastoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study characterized two patient-derived orthotopic xenograft (PDOX) models of glioblastoma (GBM) using advanced MRI techniques. The findings reveal physiological properties of untreated GBM, supporting their use in evaluating new anti-glioma therapies.
Area Of Science
- Radiology and Imaging
- Oncology
- Preclinical Research
Background
- Glioblastoma (GBM) is an aggressive brain tumor with limited treatment options.
- Patient-derived orthotopic xenograft (PDOX) models offer valuable preclinical tools for studying GBM.
- Characterizing the physiological properties of GBM PDOX models is crucial for effective therapeutic development.
Purpose Of The Study
- To characterize the physiological properties of two distinct GBM PDOX models using advanced MRI techniques.
- To evaluate the suitability of these models for preclinical assessment of novel anti-glioma therapies.
- To establish imaging biomarkers for longitudinal, minimally invasive treatment effect evaluations.
Main Methods
- Two GBM neurosphere cell lines (HF3016 and HF3177) were implanted orthotopically in athymic rats.
- Dynamic contrast-enhanced (DCE) MRI, continuous arterial spin-labeling, and diffusion-weighted imaging were employed.
- Voxel-wise analysis using Patlak, extended Patlak, and Logan graphical methods was performed to estimate physiological parameters.
Main Results
- Key vascular and physiological parameters (Ktrans, ve, vp, VD, ADC, TBF) showed slight variations between models, but differences were not statistically significant.
- Tumor flux (Flux) estimates strongly correlated with distribution volume (VD) at the tumor rim in both models.
- The characterized GBM PDOX models exhibit physiological properties representative of human GBM.
Conclusions
- The studied GBM PDOX models possess relevant physiological and genetic characteristics of human GBM.
- These models are suitable for preclinical evaluation of novel anti-glioma therapies.
- Imaging biomarkers derived from these models can facilitate longitudinal, minimally invasive assessments of treatment efficacy.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.